We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Eicosapentaenoic acid at a dose of 4 g per day reduced ...
--Dosed first patient in Emerge, the first Phase 3 study of MM120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD); 12-week topline data anticipated in 2H 2026-- --Enrollment on ...
Mood symptoms alone do not account for the extent of disability associated with MDD. 12 Cognitive impairment, 1 of the 9 core symptoms of MDD (see Table 1), is significantly associated with impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback